The global soft-tissue robotic-assisted surgery (RAS) market is undergoing structural realignment, characterised by accelerating clinical adoption, broadening procedural indications, and an intensifying multi-platform challenge to incumbent monopolies. On September 1st, 2026, Medtronic plc announced an approximately $700 million strategic investment in Cornerstone Robotics, a Hong Kong-headquartered surgical robotics innovator. Concurrently, Medtronic secured exclusive commer

The Australian Digital Health Agency (ADHA) has finalised an open market procurement awarding Accenture Australia Pty Ltd a $161.6 million contract to deliver Application Support and Maintenance (ASM) services for the national My Health Record (MHR) infrastructure and associated API gateway. This procurement decision follows scrutiny from the Australian National Audit Office (ANAO), which published a performance audit detailing historical governance failures, uncompeted contr

The structural architecture of private capital deployment within lower middle market (LMM) healthcare and healthcare technology is undergoing a fundamental transformation. Historically, single family and multi family offices participated in middle market private equity primarily as passive Limited Partners (LPs), committing capital to traditional blind pool buyout funds or selectively participating in co-investments managed by institutional general partners (GPs).

The global medical imaging market is undergoing a structural transition from fragmented, analog operational models to centralised, API-driven infrastructure layers. Scan.com’s $220 million capital raise marks a critical inflection point in this market shift, establishing the capital foundation required to consolidate the fragmented United States diagnostic ecosystem. By pairing growth equity with non dilutive acquisition debt facilities, the organisation is accelerating the d

The United Kingdom occupational health (OH) market is undergoing an unprecedented structural consolidation driven by private equity capital deployment, corporate carve outs, and buy and build strategies. Valued between £1.5 billion and £2.0 billion and expanding at an annual growth rate of 6% to 9%, the sector sits at the intersection of acute macroeconomic pressures, severe healthcare labour constraints and evolving statutory obligations for employers. Over the past 24 month

The global biopharmaceutical and medical technology (MedTech) sectors have entered a period of structural dealmaking transformation. Historically, large scale mergers and acquisitions (M&A) served as the primary instrument for multinational pharmaceutical corporations (MNCs) seeking to replenish depleted R&D pipelines, acquire proprietary drug discovery platforms and secure top-line growth. However, the economic rationale underpinning transformative M&A has been reshaped by a

Electronic Health Record (EHR) systems have historically functioned as passive databases of clinical documentation, billing records, and retrospective patient data. Epic Systems is executing a structural transition to convert its core platform into an active, autonomous enterprise command centre. Commanding 43.7% of the acute-care EHR market in the United States, with software operating across more than 3,700 hospitals and maintaining medical records for over 325 million pati

The European Healthcare Technology (HealthTech), Medical Technology (MedTech), and Healthcare Artificial Intelligence (AI) sectors have entered a period of structural realignment following the end of the Zero Interest Rate Policy (ZIRP) era. Enterprise valuations across the digital health ecosystem are no longer driven by speculative top-line revenue growth. Instead, modern valuation models prioritise capital efficiency, demonstrated unit economics, verifiable clinical utili

The rapid evolution of artificial intelligence (AI) has reoriented global discussions regarding technological innovation, shifting the analytical focus from routine productivity gains to fundamental civilizational transformation. Central to this transformation is the perspective articulated by Microsoft co-founder and philanthropist Bill Gates, who posits that artificial intelligence represents a technological leap as consequential as the development of the microprocessor, pe

This Week in European HealthTech, MedTech and Health AI: 28th August 2026. Funding and Clinical Workflow Platforms: Venture capital continues to concentrate in clinical backend operations and interoperability. Following significant mid-market rounds across the UK and Nordics, enterprise care orchestration tools and administrative AI platforms are gaining major institutional support to reduce provider burnout and streamline electronic health record (EHR) integration.

Key Insights from J.P.Morgan's 'Trends driving the healthcare industry today' report. Private Equity Capital Has Re-entered the Market: Healthcare private equity reached record global deal values in 2025, supported by roughly $1.3 trillion in dry powder sitting on the sidelines waiting to be deployed. Deal Math and Return Thresholds Have Reset: Market dynamics have tightened significantly, with distributions to Limited Partners (LPs) standing around 15% of Net Asset Value (NA

On August 27th, 2026, Temple, the health-technology venture co-founded by Eternal Ltd Vice Chairman Deepinder Goyal and former Zomato technology leader Ram Singla, announced the full acquisition of Longevous, an evidence-based longevity medicine practice based in London. Although financial terms of the transaction were not publicly disclosed, the acquisition represents a key structural pivot for Temple as it transitions from speculative hardware engineering toward institution

The digital health sector has moved past the phase of superficial algorithmic positioning. Founders who spend critical operational cycles worrying if their platforms are "AI-enough" are optimising for the wrong metric. Artificial intelligence is an enabling infrastructure technology; it is not a standalone business model or enterprise moat.

The strategic expansion of the partnership between Salesforce and Anthropic, designated as Claudeforce, represents a foundational shift in how regulated healthcare and life sciences enterprises deploy artificial intelligence. By embedding Anthropic’s frontier Claude models directly into Salesforce’s Agentforce 360 platform, Health Cloud, Life Sciences Cloud, and Slack, the collaboration addresses the historic trade-off between advanced model intelligence and strict enterprise

The integration of generative artificial intelligence across healthcare delivery, payer operations, biopharmaceutical research and clinical trials represents one of the fastest-growing enterprise technology markets. Driven by clinical workforce burnout, rising administrative costs and the need to compress drug discovery timelines, spending on domain specific artificial intelligence software and infrastructure has accelerated rapidly. Within this expanding landscape, Anthropi